Patents by Inventor Sharma Pankaj KESHAV

Sharma Pankaj KESHAV has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Highly sensitive immunoassay for rapid quantification of meningococcal capsular polysaccharide antigens
    Patent number: 10365272
    Abstract: The present disclosure relates to the field of immunoassays for Gram negative bacteria, in particular N. meningitidis. The disclosure provides a simple and affordable immunoassay to quantitate polysaccharides in meningococcal vaccines for the evaluation of antigen content and lot-to-lot manufacturing consistency. The inventors have found a Sandwich ELISA that can be applicable for the quantitation and identification of N. meningitidis serogroup X polysaccharide in a multivalent meningococcal polysaccharide-protein conjugate vaccine as well as in a multivalent meningococcal plain polysaccharide vaccine. Said assay employs a polyclonal antibody as capture antibody and a novel monoclonal antibody against serogroup X polysaccharide as detection antibody. Further the assay is rapid, robust and reproducible.
    Type: Grant
    Filed: July 24, 2015
    Date of Patent: July 30, 2019
    Assignee: SERUM INSTITUTE OF INDIA PRIVATE LIMITED
    Inventors: Kale Sameer Manohar, Sharma Pankaj Keshav, Gairola Sunil Jagdishprasad
  • HIGHLY SENSITIVE IMMUNOASSAY FOR RAPID QUANTIFICATION OF MENINGOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGENS
    Publication number: 20160025719
    Abstract: The present disclosure relates to the field of immunoassays for Gram negative bacteria, in particular N. meningitidis. The disclosure provides a simple and affordable immunoassay to quantitate polysaccharides in meningococcal vaccines for the evaluation of antigen content and lot-to-lot manufacturing consistency. The inventors have found a Sandwich ELISA that can be applicable for the quantitation and identification of N. meningitidis serogroup X polysaccharide in a multivalent meningococcal polysaccharide-protein conjugate vaccine as well as in a multivalent meningococcal plain polysaccharide vaccine. Said assay employs a polyclonal antibody as capture antibody and a novel monoclonal antibody against serogroup X polysaccharide as detection antibody. Further the assay is rapid, robust and reproducible.
    Type: Application
    Filed: July 24, 2015
    Publication date: January 28, 2016
    Inventors: Kale Sameer MANOHAR, Sharma Pankaj KESHAV, Gairola Sunil JAGDISHPRASAD